Analytically confirmed illicit and novel psychoactive drug use in Western Australian emergency departments: initial results from the Emerging Drugs Network of Australia (EDNA)

References

• Australian Institute of Health and Welfare. National drug strategy household survey 2019. (Drug Statistics series no 32. PHE 270.) Canberra: AIHW; 2020.
   Google Scholar
• Australian Institute of Health and Welfare. Alcohol, tobacco & other drugs in Australia. Canberra: AIHW; 2022. [cited Oct 2022]. https://www.aihw.gov.au/reports/alcohol/alcohol-tobacco-other-drugs-australia
   Google Scholar
• Chrzanowska A, Man N, Sutherland R, et al. Trends in drug-related hospitalisations in Australia, 1999-2020. Drug trends bulletin series. Sydney: national Drug and Alcohol Research Centre, UNSW. 2021.
   Google Scholar
• Di Rico R, Nambiar D, Stoové M, et al. Drug overdose in the ED: a record linkage study examining emergency department ICD-10 coding practices in a cohort of people who inject drugs. BMC Health Serv Res. 2018;18(1):1–9. doi: 10.1186/s12913-018-3756-8.
   PubMedGoogle Scholar
• Wood DM, De La Rue L, Hosin AA, et al. Poor identification of emergency department acute recreational drug toxicity presentations using routine hospital coding systems: the experience in Denmark, Switzerland and the UK. J Med Toxicol. 2019;15(2):112–120. doi: 10.1007/s13181-018-0687-z.
   PubMed Web of Science ®Google Scholar
• Helander A, Bäckberg M, Beck O. Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: experiences from the STRIDA project. PLoS One. 2020;15(4):e0232038. doi: 10.1371/journal.pone.0232038.
   PubMed Web of Science ®Google Scholar
• Sutherland R, Allsop S, Peacock A. New psychoactive substances in Australia: patterns and characteristics of use, adverse effects, and interventions to reduce harm. Curr Opin Psychiatry. 2020;33(4):343–351. doi: 10.1097/YCO.0000000000000606.
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime. Current NPS threats. Volume III. San Francisco (CA): United Nations Office on Drugs and Crime; 2020.
   Google Scholar
• Wood DM, Ceronie B, Dargan PI. Healthcare professionals are less confident in managing acute toxicity related to the use of new psychoactive substances (NPS) compared with classical recreational drugs. QJM. 2016;109(8):527–529. doi: 10.1093/qjmed/hcv208.
   PubMed Web of Science ®Google Scholar
• McCutcheon D, Raghavan M, Soderstrom J, et al. An early warning system for emerging drugs of concern in the emergency department: protocol for the Western Australian illicit substance evaluation (WISE) study. Emerg Med Australas. 2019;31(3):411–416. doi: 10.1111/1742-6723.13185.
   PubMed Web of Science ®Google Scholar
• Monte AA, Hopkinson A, Saben J, et al. The psychoactive surveillance consortium and analysis network (PSCAN): the first year. Addiction. 2020;115(2):270–278. doi: 10.1111/add.14808.
   PubMed Web of Science ®Google Scholar
• Smith JL, McCutcheon D, Weber C, et al. ‘Trial by fire’: an online survey exploring confidence of junior doctors in managing toxicology presentations to the emergency department. Drug Alcohol Rev. 2022;41(7):1554–1564. doi: 10.1111/dar.13526.
   PubMed Web of Science ®Google Scholar
• Liakoni E, Yates C, Dines AM, et al. Acute recreational drug toxicity: comparison of self-reports and results of immunoassay and additional analytical methods in a multicenter european case series. Medicine. 2018;97(5):e9784. doi: 10.1097/MD.0000000000009784.
   PubMed Web of Science ®Google Scholar
• Buxton JA, Spearn B, Amlani A, et al. The British Columbia drug overdose and alert partnership: interpreting and sharing timely illicit drug information to reduce harms. JCSWB. 2019;4(1):4–9. doi: 10.35502/jcswb.92.
   Google Scholar
• Smith JL, Soderstrom J, Dawson A, et al. The emerging drugs network of Australia: a toxicosurveillance system of illicit and emerging drugs in the emergency department. Emerg Med Australas. 2022;34(1):58–64. doi: 10.1111/1742-6723.13839.
   PubMed Web of Science ®Google Scholar
• Smith JL, Stockham P, Oosthuizen F. Emerging drugs network of Australia: a national approach to toxicosurveillance. TIAFT Bull. 2022;52(2):17–21.
   Google Scholar
• Australasian College for Emergency Medicine. Policy on the Australasian Triage Scale. Report No. P06. Victoria: Australasian College for Emergency Medicine; 2013.
   Google Scholar
• Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. doi: 10.1016/j.jbi.2019.103208.
   PubMed Web of Science ®Google Scholar
• National Health and Medical Research Council, Australian Research Council, Universities Australia. National statement on ethical conduct in human research 2007. Canberra: NHMRC; 2018. [updated 2018]. http://www.nhmrc.gov.au/guidelines/publications/e72
   Google Scholar
• Miró Ò, Waring WS, Dargan PI, et al. Variation of drugs involved in acute drug toxicity presentations based on age and sex: an epidemiological approach based on european emergency departments. Clin Toxicol. 2021;59(10):896–904. doi: 10.1080/15563650.2021.1884693.
   PubMed Web of Science ®Google Scholar
• Darke S, Peacock A, Duflou J, et al. Characteristics of fatal ‘novel’ benzodiazepine toxicity in Australia. Forensic Sci Int. 2022;331:111140. doi: 10.1016/j.forsciint.2021.111140.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Sara G, McKetin R, et al. Crystalline methamphetamine use and methamphetamine‐related harms in Australia. Drug Alcohol Rev. 2017;36(2):160–170. Mardoi: 10.1111/dar.12426.
   PubMed Web of Science ®Google Scholar
• Dines AM, Wood DM, Yates C, et al. Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN). Clin Toxicol. 2015;53(9):893–900. doi: 10.3109/15563650.2015.1088157.
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime. Current NPS threats: Volume IV. San Francisco (CA): United Nations Office on Drugs and Crime; 2021.
   Google Scholar
• Arens AM, van Wijk XM, Vo KT, et al. Adverse effects from counterfeit alprazolam tablets. JAMA Intern Med. 2016;176(10):1554–1555. doi: 10.1001/jamainternmed.2016.4306.
   PubMed Web of Science ®Google Scholar
• Brunetti P, Giorgetti R, Tagliabracci A, et al. Designer benzodiazepines: a review of toxicology and public health risks. Pharmaceuticals. 2021;14(6):560. doi: 10.3390/ph14060560.
   Web of Science ®Google Scholar